Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England which develops inhaled medicines and makes inhaler devices. It was listed on the London Stock Exchange (LSE) until it was acquired by Philip Morris International in September 2021.
On 7 January 2025, Molex Inc. announced that it had completed the purchase of the company through an affiliate.
History
Vectura was formed in 1997 at the University of Bath as a start-up pharmaceuticals business.[3] In 1999 it acquired Co-ordinated Drug Development and the Centre for Drug Formulation Studies.[4] The company moved from the university campus to a site at Chippenham, Wiltshire in 2002.[3]